Hye-Jung Kim

Company: Dana-Farber Cancer Institute
Job title: Lead Investigator
Seminars:
Helios, Treg Stability & Contribution to Anti-Tumor Immunity 12:00 pm
Discussing Helios as a common transcription factor for CD8 and CD4 Treg Targeting Helios to achieve selective induction of Treg instability under inflammatory conditionsRead more
day: Pre-Conference Focus Day